Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19915048rdf:typepubmed:Citationlld:pubmed
pubmed-article:19915048lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C0166417lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:19915048lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:19915048pubmed:issue11lld:pubmed
pubmed-article:19915048pubmed:dateCreated2009-11-20lld:pubmed
pubmed-article:19915048pubmed:abstractTextProtective humoral immune responses critically depend on the optimal differentiation of B cells into Ab-secreting cells. Because of the important role of Abs in fighting infections and in successful vaccination, it is imperative to identify mediators that control B cell differentiation. Activation of B cells through TLR9 by CpG-DNA induces plasma cell differentiation and Ab production. Herein, we examined the role of the peroxisome proliferator-activated receptor (PPAR)gamma/RXRalpha pathway on human B cell differentiation. We demonstrated that activated B cells up-regulate their expression of PPARgamma. We also show that nanomolar levels of natural (15-deoxy-Delta(12,14)-prostaglandin J(2)) or synthetic (rosiglitazone) PPARgamma ligands enhanced B cell proliferation and significantly stimulated plasma cell differentiation and Ab production. Moreover, the addition of GW9662, a specific PPARgamma antagonist, abolished these effects. Retinoid X receptor (RXR) is the binding partner for PPARgamma and is required to produce an active transcriptional complex. The simultaneous addition of nanomolar concentrations of the RXRalpha ligand (9-cis-retinoic acid) and PPARgamma ligands to CpG-activated B cells resulted in additive effects on B cell proliferation, plasma cell differentiation, and Ab production. Furthermore, PPARgamma ligands alone or combined with 9-cis-retinoic acid enhanced CpG-induced expression of Cox-2 and the plasma cell transcription factor BLIMP-1. Induction of these important regulators of B cell differentiation provides a possible mechanism for the B cell-enhancing effects of PPARgamma ligands. These new findings indicate that low doses of PPARgamma/RXRalpha ligands could be used as a new type of adjuvant to stimulate Ab production.lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:languageenglld:pubmed
pubmed-article:19915048pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19915048pubmed:statusMEDLINElld:pubmed
pubmed-article:19915048pubmed:monthDeclld:pubmed
pubmed-article:19915048pubmed:issn1550-6606lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:PhippsRichard...lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:Simpson-Haida...lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:BagloleCaroly...lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:MurantThomas...lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:BernardMatthe...lld:pubmed
pubmed-article:19915048pubmed:authorpubmed-author:Garcia-BatesT...lld:pubmed
pubmed-article:19915048pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19915048pubmed:day1lld:pubmed
pubmed-article:19915048pubmed:volume183lld:pubmed
pubmed-article:19915048pubmed:ownerNLMlld:pubmed
pubmed-article:19915048pubmed:authorsCompleteYlld:pubmed
pubmed-article:19915048pubmed:pagination6903-12lld:pubmed
pubmed-article:19915048pubmed:dateRevised2011-9-26lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:meshHeadingpubmed-meshheading:19915048...lld:pubmed
pubmed-article:19915048pubmed:year2009lld:pubmed
pubmed-article:19915048pubmed:articleTitlePeroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.lld:pubmed
pubmed-article:19915048pubmed:affiliationDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.lld:pubmed
pubmed-article:19915048pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19915048pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:19915048pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19915048pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:5468entrezgene:pubmedpubmed-article:19915048lld:entrezgene
entrez-gene:5743entrezgene:pubmedpubmed-article:19915048lld:entrezgene
entrez-gene:639entrezgene:pubmedpubmed-article:19915048lld:entrezgene
entrez-gene:6256entrezgene:pubmedpubmed-article:19915048lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19915048lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19915048lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19915048lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19915048lld:entrezgene